Evidence-aware assessment
Use program documents and structured context to identify what is present, what remains unclear, and what appears absent.
Evaluate program evidence against the intended pathway and authority context, separate critical issues from lower-priority work, and turn the findings into a sequenced readiness plan.
What it does
Use program documents and structured context to identify what is present, what remains unclear, and what appears absent.
Frame readiness against the selected authority, submission type, development stage, and intended regulatory objective.
Distinguish issues that may affect safety, reviewability, clinical progression, or filing readiness from routine follow-up work.
Translate findings into clear next steps, dependencies, accountable owners, and realistic sequencing.
Summarize readiness by domain so teams and executives can see where attention is needed without losing the underlying detail.
Use the same findings in submission planning, authority simulation, reporting, regulatory chat, and presentations.
Connected workflow
Choose the program, authority, pathway, development stage, and decision the assessment must support.
Bring in the relevant documents, prior decisions, assumptions, and source material.
Evaluate gap statements, severity, rationale, evidence references, and uncertainty.
Convert confirmed gaps into an accountable remediation and submission-readiness plan.
Designed for decisions
Gulfstream connects source material, regulatory reasoning, planning, and deliverables so teams do not have to reconstruct the same work in disconnected systems.
It is a structured system for comparing the current evidence, documents, decisions, and program state against the requirements and expectations relevant to a regulatory objective. Useful software should preserve sources, rationale, uncertainty, severity, and recommended follow-through—not just generate a checklist.
Gulfstream can support an IND readiness workflow across administrative, CMC, nonclinical, clinical, and program-planning domains. The assessment must be configured for the specific product and reviewed by qualified personnel against current FDA requirements and guidance.
No. Gulfstream is decision-support software. Qualified personnel remain responsible for selecting the assessment basis, confirming the evidence, challenging findings, interpreting authority expectations, and approving actions.
Yes. Program Mode is designed to work with approved project documents and designated regulatory sources. Customer content remains subject to Gulfstream’s privacy, access-control, and data-handling practices.
Confirmed findings can inform tasks, dependencies, owners, target dates, reporting, and decision checkpoints in the connected Submission Planner instead of being left in a static assessment report.
Gulfstream supports global regulatory work, including FDA, EMA, MHRA, Health Canada, PMDA, TGA, NMPA, and other authorities. The exact assessment basis should reflect the product, region, pathway, and current source set selected by the user.
Continue exploring
Review the domains and questions that should be resolved before an initial IND.
Learn moreConvert confirmed readiness gaps into sequenced, accountable work.
Learn moreCommunicate assessment findings in an editable, company-branded presentation.
Learn moreMove regulatory work forward